Palo Santo
Overview
Palo Santo is a U.S.-based venture capital firm focused on increasing the supply of clinically effective and accessible mental health and addiction treatment solutions. The firm targets a diverse range of companies offering innovative solutions across biopharma, drug development, digital therapeutics, healthcare services, and tech-enabled solutions to address the growing global mental health crisis. From cutting-edge science to commercial application, Palo Santo's portfolio includes more than 20 companies focused on advancing the field of psychedelic medicines and expanding patient access and affordability. The firm has made significant investments in companies such as atai Life Sciences, Reset Pharma, Field Trip Health, Tactogen, Eleusis, Bexson Biomedical, Ksana Health, neuroCare, Bright Minds, Diamond Therapeutics, and Gilgamesh, among others. Palo Santo's team brings decades of experience in investing and portfolio building in private equity and venture capital, along with expertise in life sciences and healthcare services. Additionally, the firm is supported by leading academics and advisors in psychedelic science. Palo Santo's mission is to drive clinical development and FDA approval of psychedelic therapies that are poised to become the future standard of care. The firm actively works to support and synergize its portfolio by connecting founders, advisors, and key opinion leaders with a collaborative ethos in mind. By investing in early-stage, high-growth opportunities, Palo Santo aims to have a profound impact on treating a wide range of conditions such as depression, PTSD, anxiety, OCD, addiction, chronic or neuropathic pain, neurodegenerative diseases, and a range of inflammatory-related illnesses.
Portfolio Companies
Reach Palo Santo directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Palo Santo
What sectors does Palo Santo invest in?
Palo Santo invests in Healthcare, Pharmaceuticals, Biotechnology, Therapeutics, Wellness and Biopharmaceuticals, and is based in Illinois, United States. Palo Santo is listed as a venture capital in the ConnectSafely investor database.
What stage does Palo Santo invest at?
Palo Santo backs companies at Seed, Early Stage, Series A, Series B and Growth.
Which regions does Palo Santo invest in?
Palo Santo invests across United States.
Who are the partners at Palo Santo?
Team members listed for Palo Santo include Daniel Goldberg (Co-Founder & Partner) and Tony Eisenberg (Partner and Co-Founder).
What companies has Palo Santo invested in?
Palo Santo's portfolio includes ATAI Life Sciences, Ksana Health, Gilgamesh, Bexson Biomedical, Bright Minds, Reset Pharma, Field Trip Health and Tactogen.
How do I contact Palo Santo?
Palo Santo's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
